fludarabine has been researched along with B-Cell Leukemia in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 13 (72.22) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Bar, M; Bezerra, ED; Cassaday, RD; Chapuis, AG; Chou, CK; Cowan, AJ; Fiorenza, S; Gauthier, J; Green, DJ; Hawkins, RM; Hirayama, AV; Jamieson, AW; Kiem, HP; Kimble, EL; Maloney, DG; Milano, F; Pender, BS; Phi, TD; Riddell, SR; Shadman, M; Sheih, A; Steinmetz, RN; Till, BG; Turtle, CJ; Vakil, A | 1 |
| Cao, J; Chen, W; Cheng, H; Jing, G; Li, H; Qi, K; Qiao, J; Shi, M; Wang, G; Wu, Q; Xu, K; Zeng, L; Zhao, J; Zheng, J | 1 |
| Chinratanalab, W; Engelhardt, BG; Goodman, SA; Greer, JP; Jagasia, M; Kassim, AA; Kennedy, VE; Savani, BN; Sengsayadeth, S | 1 |
| Becker, ST; Klapper, W; Repp, R; Sinis, N; Warnke, PH; Wiltfang, J | 1 |
| Byrd, JC; Hoke, E; Jacobson, R; Larson, RA; Morrison, VA; Park, K; Peterson, BL; Rai, K; Schiffer, CA; Vardiman, JW | 1 |
| Abdul-Hai, A; Amir, G; Or, R; Polliack, A; Weiss, L | 1 |
| Dumontet, C; Fernández-Calotti, P; Galmarini, CM; Gamberale, R; Geffner, J; Giordano, M; Jordheim, L; Sánchez-Avalos, J | 1 |
| Cantero, E; Casanova, B; de la Fuente, MT; Garcia-Marco, J; Garcia-Pardo, A; Hernández del Cerro, M; Silva, A | 1 |
| Gadea, I; Llamas, P; Prieto, E; Román, A; Santos, AB; Subirá, D; Tomás, JF | 1 |
| Briones, J; Forné, I; Juarez, C; Martinez-Gallo, M; Martinez-Lostao, L; Rodriguez-Sanchez, JL; Sierra, J | 1 |
| Choudhury, A; Kiaii, S; Lundin, J; Mellstedt, H; Mozaffari, F; Osterborg, A; Rezvany, R | 1 |
| Chang, VT; Harrison, J; Mansour, A; Raveche, E; Srinivas, S | 1 |
| Cebula, B; Linke, A; Robak, P; Robak, T; Smolewski, P | 1 |
| Bowen, AL; Catovsky, D; Dyer, MJ; Emmett, E; Matutes, E; Zomas, A | 1 |
| Andrieu, V; Carbon, C; Couvelard, A; Encaoua, R; Grange, MJ | 1 |
| Catovsky, D; Dearden, CE; Matutes, E | 1 |
| Beer, M; Byrd, JC; Grever, MR; Lucas, MA; Waselenko, JK | 1 |
| Brandt, L; Glimelius, B; Kimby, E; Nygren, P | 1 |
2 review(s) available for fludarabine and B-Cell Leukemia
| Article | Year |
|---|---|
Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clinical Trials, Phase II as Topic; Disease-Free Survival; Drug Resistance, Neoplasm; Drug Synergism; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Remission Induction; Vidarabine | 2000 |
A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Humans; Leukemia, B-Cell; Prednisolone; Prognosis; Recurrence; Risk Factors; Salvage Therapy; Vidarabine; Vincristine | 2001 |
2 trial(s) available for fludarabine and B-Cell Leukemia
| Article | Year |
|---|---|
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies.
Topics: Adult; Aged; Antigens, CD19; Cell Proliferation; Cyclophosphamide; Cytokine Release Syndrome; Female; Humans; Immunotherapy, Adoptive; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Progression-Free Survival; T-Lymphocytes; Treatment Outcome; Vidarabine | 2021 |
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Leukemia, B-Cell; Male; Middle Aged; Risk Factors; Rituximab; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vidarabine | 2003 |
14 other study(ies) available for fludarabine and B-Cell Leukemia
| Article | Year |
|---|---|
Humanized CD19-specific chimeric antigen-receptor T-cells in 2 adults with newly diagnosed B-cell acute lymphoblastic leukemia.
Topics: Aged; Antigens, CD19; B-Lymphocytes; Cell Separation; Cyclophosphamide; Female; Flow Cytometry; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy, Adoptive; Kinetics; Leukemia, B-Cell; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Antigen, T-Cell; Remission Induction; T-Lymphocytes; Vidarabine | 2019 |
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Calcineurin Inhibitors; Cyclophosphamide; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, B-Cell; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Rituximab; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2016 |
Massive swelling of the cervical region: an uncommon manifestation of B cell chronic lymphocytic leukemia.
Topics: Adipose Tissue; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Female; Humans; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lipectomy; Lipomatosis, Multiple Symmetrical; Lymph Nodes; Middle Aged; Neck; Vidarabine | 2008 |
Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintains effective graft-versus-leukemia effect after allogeneic stem cell transplantation in murine lymphocytic leukemia.
Topics: Animals; Apoptosis; Crosses, Genetic; Cyclophosphamide; Drug Therapy, Combination; Graft vs Host Disease; Leukemia, B-Cell; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Skin; Spleen; Stem Cell Transplantation; Transplantation, Homologous; Vidarabine | 2003 |
In vitro susceptibility of CD4+ and CD8+ T cell subsets to fludarabine.
Topics: Aged; Aged, 80 and over; Apoptosis; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Survival; Cells, Cultured; Chronic Disease; Female; Humans; Immunosuppressive Agents; Leukemia, B-Cell; Male; Middle Aged; Statistics, Nonparametric; Vidarabine | 2003 |
Involvement of p53 in alpha4beta1 integrin-mediated resistance of B-CLL cells to fludarabine.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Cell Adhesion; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Electrophoresis, Polyacrylamide Gel; Humans; Immunoblotting; Integrin alpha4beta1; Leukemia, B-Cell; Ligands; Lysine; Proto-Oncogene Proteins c-bcl-2; Sequence Analysis, DNA; Signal Transduction; Tumor Suppressor Protein p53; Up-Regulation; Vidarabine | 2003 |
Aspergillus fumigatus: a rare cause of vertebral osteomyelitis.
Topics: Aspergillus fumigatus; Humans; Leukemia, B-Cell; Opportunistic Infections; Osteomyelitis; Purine Nucleosides; Spinal Diseases; Vidarabine | 2004 |
Fludarabine-induced apoptosis in CD19+/CD5+B-CLL cells is a direct and nurse-like-cell independent effect.
Topics: Aged; Annexin A5; Antigens, CD19; Antineoplastic Agents; Apoptosis; CD5 Antigens; Cell Death; Cell Survival; Female; Flow Cytometry; Humans; Immunophenotyping; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Male; Middle Aged; Monocytes; Time Factors; Vidarabine | 2004 |
Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia: long-term effects of fludarabine and alemtuzumab treatment.
Topics: Aged; Aged, 80 and over; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Female; Humans; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Male; Middle Aged; Signal Transduction; T-Lymphocytes; Time Factors; Vidarabine | 2006 |
Correlation of ZAP-70 expression in B cell leukemias to the ex vivo response to a combination of fludarabine/genistein.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Flow Cytometry; Gene Expression; Gene Expression Profiling; Genistein; Humans; Interleukin-10; Leukemia, B-Cell; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vidarabine; ZAP-70 Protein-Tyrosine Kinase | 2007 |
Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells.
Topics: Alemtuzumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cladribine; Etodolac; Humans; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Purines; Rituximab; Spectrometry, Fluorescence; Vidarabine | 2006 |
Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia.
Topics: Administration, Cutaneous; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Humans; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Male; Recurrence; Vidarabine | 1997 |
Leukemic pleural effusion in B-cell prolymphocytic leukemia.
Topics: Aged; Antibodies; Antigens, CD20; Antineoplastic Agents; Humans; Immunohistochemistry; Leukemia, B-Cell; Leukemia, Prolymphocytic; Male; Pleural Effusion, Malignant; Remission Induction; Tomography Scanners, X-Ray Computed; Vidarabine | 1998 |
Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Immunosuppressive Agents; Leukemia; Leukemia, B-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Leukemia, T-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell; Pentostatin; Sezary Syndrome; Survival Rate; Vidarabine | 2000 |